EE427 Annual Cost Savings From the Use of Empagliflozin Over DPP4I in Select Asia-Pacific Countries – Estimates Based on the Emprise East Asia Study
Abstract
Authors
L Varghese G Alcantara P Germanos Y Sumettavanich A Das J Gordon